Similar articles

• Differential cardiovascular effects of calcium channel blocking agents: potential mechanisms.

  Millard RW, Lathrop DA, Grupp G, Ashraf M, Grupp IL, Schwartz A. Millard RW, et al. Am J Cardiol. 1982 Feb 18;49(3):499-506. doi: 10.1016/s0002-9149(82)80002-7. Am J Cardiol. 1982. PMID: 6277175
• Calcium channel blocking drugs.

  Johnston WE, Lowenstein E. Johnston WE, et al. Contemp Anesth Pract. 1983;7:163-91. Contemp Anesth Pract. 1983. PMID: 6309475 Review. No abstract available.
• [Myocardial cellular mechanism of action of calcium antagonists].

  Ferrari R, Boffa GM, Ciampalini G, Ceconi C. Ferrari R, et al. Cardiologia. 1985 Feb;30(2):77-89. Cardiologia. 1985. PMID: 3905004 Review. Italian. No abstract available.
• Protection of infarcting myocardium by slow channel inhibitors. Comparative effects of verapamil, nifedipine, and diltiazem in the coronary-ligated, isolated working rat heart.

  Hamm CW, Opie LH. Hamm CW, et al. Circ Res. 1983 Feb;52(2 Pt 2):I129-38. Circ Res. 1983. PMID: 6831647 No abstract available.
• Hypertension: calcium-blocking agents in treatment.

  Ambrose JE. Ambrose JE. J Am Osteopath Assoc. 1984 Jan;83(5):353-60. J Am Osteopath Assoc. 1984. PMID: 6321407 Review. No abstract available.